When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
In 2015, Chinese biotechnology company Revotek released a 3d-bioprinter that fabricates blood vessels using a bio-ink made from stem cells. Just before the close of 2016, Kang Yujian,…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Researchers have developed a vapor delivery system for a sialic acid-coated nanoparticle that is intended to prevent the influenza A virus from binding to sialic acid on patients’…
An injection of cells using only a local anesthetic might be able to deliver the same benefits as a full pancreatic transplant without the tumultuous side effects.
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
The use of AR in medical education is gaining in popularity, almost as fast as the technology is progressing. Check out how far they've come since our last…
Scientists have identified a protein known as DNA-dependent activator of interferon (DAI) to be the trigger for cell death when cells become infected with influenza A. Mice that…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
